CliffBio
small molecule

TOVIAZ

FESOTERODINE FUMARATE

Loss of exclusivityDecember 2027latest FDA-listed patent expiry
CompanyPfizer →See this company's full patent-cliff portfolio

Drug detail

Brand nameTOVIAZ
Active ingredientFESOTERODINE FUMARATE
Strength8MG
Dosage formTABLET, EXTENDED RELEASE
RouteORAL
ModalitySmall molecule
FDA approvalOctober 2008
Marketing statusRX

Listed patents

PatentExpiresType
7807715*PEDDecember 2027—
8088398*PEDDecember 2027—
8501723*PEDDecember 2027—
8088398June 2027product
7807715June 2027product
8501723June 2027product

More from Pfizer

Source: FDA Orange Book, layered on the CliffBio company graph. Cliff dates are the latest FDA-listed patent expiry; estimates are projections, not legal advice.